Alternate Test Names:
Antibodies to FLI-1 are no longer available at PhenoPath, largely because there are far superior tests available for the former clinical applications of FLI-1. Antibodies to ERG are strongly recommended as a replacement for the identification of endothelial cells and vascular neoplasms, and antibodies to NKX2.2 are recommended as a replacement for the identification of PNET/ES. Alternatively, FISH studies looking for the presence of a translocation involving the EWSR gene is considered a ‘gold standard’ for the identification of this latter tumor.
Schedule: Monday - Friday